A Review on Analytical Method Development and Validation for The Simultaneous Estimation of Lamivudine and Stavudine by RP-HPLC

2. Rationale for Simultaneous RP-HPLC Estimation:

Lamivudine and stavudine are widely used together in fixed-dose antiretroviral formulations for HIV treatment, requiring accurate simultaneous quantification. RP-HPLC is the preferred analytical technique due to its high resolution, sensitivity, and reproducibility¹⁶. Both drugs exhibit adequate UV absorbance and compatibility with aqueous–organic mobile phases, enabling efficient detection. Differences in polarity and retention behavior make simpler methods like UV spectrophotometry less reliable¹⁷. A validated simultaneous RP-HPLC method ensures precise separation, stability indication, regulatory compliance (ICH guidelines), and improved quality control efficiency^18-20.

3. Selection of Chromatographic Conditions:

Selection of optimized chromatographic conditions is essential for reliable simultaneous RP-HPLC estimation of lamivudine and stavudine. A C18 reversed-phase column is preferred due to good retention, peak symmetry, and reproducibility²¹. An aqueous buffer combined with acetonitrile or methanol is used as the mobile phase, with pH carefully controlled to improve resolution and reduce peak tailing. Flow rate and column temperature are optimized to balance analysis time and separation efficiency²². UV detection at a common wavelength ensures sensitive and accurate simultaneous quantification of both drugs²³.

4. Detection Wavelength Selection:

Selection of an appropriate detection wavelength is critical for ensuring sensitivity, selectivity, and accurate quantification in RP-HPLC analysis. UV detection is preferred for lamivudine and stavudine due to its simplicity and cost-effectiveness²⁴. Both drugs exhibit overlapping UV absorption (≈265–280 nm), allowing selection of a common wavelength for simultaneous detection. Proper wavelength optimization improves signal-to-noise ratio, linearity, and quantification accuracy²⁵.It also enhances method specificity and stability-indicating capability by minimizing interference from excipients and degradation products²⁶.

5. Method Development Strategy:

The RP-HPLC method development for simultaneous estimation of lamivudine and stavudine involves systematic optimization to achieve good resolution, accuracy, and precision. Initial conditions are selected based on their physicochemical properties such as polarity, pKa, solubility, and UV absorption. Mobile phase composition, buffer pH, and organic solvent ratio are optimized to obtain symmetric peaks and proper retention²⁷. Flow rate, column temperature, and detection wavelength are adjusted to enhance sensitivity and reproducibility. System suitability parameters like resolution, tailing factor, and theoretical plates are evaluated to ensure robustness. The finalized method is selected for its reliability, simplicity, and suitability for validation and regulatory compliance²⁸.

6. Validation Parameters (as per ICH Q2 (R1)):

Specificity confirmed no interference from excipients or degradation products at the retention times of lamivudine and stavudine. Linearity showed excellent correlation (R² ≥ 0.999) across the working range²⁹. Accuracy was validated by recovery studies (98–102%), while precision demonstrated %RSD < 2%, indicating good repeatability³⁰. Low LOD and LOQ values confirmed method sensitivity. Robustness testing under small deliberate variations showed no significant impact on results. System suitability parameters (resolution, tailing factor, theoretical plates) complied with acceptance criteria, confirming reliable performance for routine analysis^31-33.

7. Comparison with Reported Analytical Methods:

Various analytical methods such as UV spectrophotometry, derivative spectrophotometry, HPTLC, RP-HPLC, and LC–MS/MS have been reported for estimation of lamivudine and stavudine³¹. UV methods are simple and economical but lack selectivity in multi-component formulations due to overlapping spectra. HPTLC offers reduced solvent use but provides lower precision and sensitivity compared to HPLC. LC–MS/MS gives excellent sensitivity but is costly and complex for routine quality control³². In comparison, a validated simultaneous RP-HPLC method offers an optimal balance of accuracy, sensitivity, cost-effectiveness, and regulatory suitability, making it ideal for routine QC and stability studies³³.

8. Forced Degradation and Stability-Indicating Capability:

A stability-indicating RP-HPLC method effectively separates lamivudine and stavudine from their degradation products without interference³⁴. Specificity is confirmed by well-resolved peaks, consistent retention times, and peak purity analysis showing no co-eluting impurities. Forced degradation studies under acidic, alkaline, oxidative, thermal, and photolytic conditions assess drug stability and ensure controlled degradation³⁵. The method accurately quantifies both drugs even in stressed samples, demonstrating sensitivity and selectivity. This confirms its suitability for stability studies, routine quality control, and regulatory compliance³⁶.

9. Regulatory and Industrial Relevance:

Development and validation of a simultaneous RP-HPLC method for lamivudine and stavudine hold significant regulatory and industrial importance³⁷. Regulatory agencies such as ICH, US FDA, and EMA require validated, stability-indicating methods complying with ICH Q2 (R1) guidelines to ensure accuracy, precision, specificity, and robustness. The method supports essential requirements like assay, content uniformity, and stability studies for fixed-dose combinations³⁸. Industrially, it reduces solvent consumption, cost, and analysis time by enabling single-run quantification. Its reproducibility, robustness, and compatibility with standard HPLC-UV systems make it highly suitable for routine quality control and global regulatory acceptance^39-40.

CONCLUSION

The developed simultaneous RP-HPLC method provides a reliable and efficient approach for quality evaluation of lamivudine–stavudine combination formulations. Optimized chromatographic conditions ensure effective separation and accurate quantification of both drugs in a single run. Validation as per ICH Q2 (R1) confirms specificity, linearity, accuracy, precision, robustness, and sensitivity. Forced degradation studies establish its stability-indicating capability, supporting regulatory submissions and shelf-life determination. Compared to other analytical methods, RP-HPLC offers an optimal balance of performance, cost-effectiveness, and practicality. Thus, the validated method is well-suited for routine quality control, industrial application, and regulatory compliance.

REFERENCES

1. International Council for Harmonisation. ICH Q2(R1): Validation of analytical procedures: text and methodology. Geneva: ICH; 2005.
2. Patel DJ, Patel MM. Analytical method validation: A regulatory perspective. J Pharm Sci Bioscientific Res. 2014;4(3):148–155.
3. Wakankar S, Kulkarni A. Stability indicating methods in pharmaceutical analysis. Int J Pharm Sci Rev Res. 2015;31(2):155–162.
4. Jain PS, Surana SJ. Stability-indicating HPLC methods for drugs—A review. Acta Chromatogr. 2016;28(1):1–15.
5. United States Pharmacopeial Convention. United States Pharmacopeia 43–NF 38. Rockville: USP; 2020.
6. British Pharmacopoeia Commission. British Pharmacopoeia. London: Stationery Office; 2020.
7. Indian Pharmacopoeia Commission. Indian Pharmacopoeia. Ghaziabad: IPC; 2018.
8. Blessy M, Patel RD, Prajapati PN, Agrawal YK. Development of forced degradation and stability indicating studies of drugs—A review. J Pharm Anal. 2014;4(3):159–165.
9. WHO. Quality assurance of pharmaceuticals: A compendium of guidelines. Geneva: World Health Organization; 2018.
10. Gandhi SV, Patil PH, Chaudhari PD. Development and validation of RP-HPLC method for lamivudine in bulk and tablet dosage form. Int J Pharm Sci Res. 2011;2(6):1562–1566.
11. Patel SA, Patel NJ. RP-HPLC method development and validation for estimation of lamivudine. Asian J Pharm Clin Res. 2012;5(3):99–102.
12. Rao JR, Reddy KR. Stability indicating RP-HPLC method for lamivudine. J Chem Pharm Res. 2013;5(8):352–357.
13. Kumar A, Mishra A. Analytical methods for antiretroviral drugs: A review. Pharm Methods. 2014;5(1):1–12.
14. Patel RB, Patel MR. RP-HPLC method for estimation of stavudine in capsule dosage form. Int J Pharm Sci Rev Res. 2010;3(2):45–48.
15. Reddy KV, Reddy MN. Stability indicating RP-HPLC method for stavudine. Int J Pharm Pharm Sci. 2012;4(4):560–564.